Acquiring Company
Schneider Electric
Acquired Company
PTC Therapeutics
Description
Schneider Electric plans to acquire PTC in an all-cash transaction valued at approximately $22.6 billion. This acquisition will enhance Schneider's portfolio in industrial software by integrating PTC's advanced CAD and lifecycle management technologies. The deal is expected to close by Q3 2027, pending necessary approvals. The merger aims to improve the digital connectivity between engineering and operational data.
Fundz sees it the moment Schneider Electric makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired PTC Therapeutics?
PTC Therapeutics was acquired by Schneider Electric, based in Paris. The deal was reported on October 5, 2026. Schneider Electric is a multinational corporation specializing in energy management and automation solutions. Schneider Electric is privately held and operates in Manufacturing.
When did Schneider Electric acquire PTC Therapeutics?
Schneider Electric's acquisition of PTC Therapeutics was reported on October 5, 2026. Schneider Electric plans to acquire PTC in an all-cash transaction valued at approximately $22.6 billion. This acquisition will enhance Schneider's portfolio in industrial software by integrating PTC's advanced CAD and lifecycle management technologies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does PTC Therapeutics do?
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. It is publicly traded (PTCT), operating in Biotechnology, and is based in South Plainfield.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.